... full citations Table H-37 Key Question 3i : Cohort study of decreasing opioid doses or of tapering off opioids versus continuation of ... full citations Table H-38 Key Question 3i : Cohort study of decreasing opioid doses or of tapering off opioids versus continuation of ...

... high-dose cyclophosphamide cohort than in the low-dose cohort (94% vs. 38%); the response rate was higher ... the MRD cohort than in the morphological disease cohort (93% vs. 50%). Of ... dose of cyclophosphamide conditioning. In an effort to overcome ...

... three RCTs 73 , 117 , 131 , and a prospective cohort 185 ): Different doses of aripiprazole are probably of little or no ... synthesis below focuses on the differences between these doses. The cohort study 185 (N = 21) investigated three high doses ( ...

... elevated bleeding risk above baseline. In one large cohort study, low-dose ASA significantly increased rates of hospitalization for bleeding ... results stratified by medication use. In the large cohort study that compared low-dose ASA users to propensity-score matched never-users, ...

... meningioma after childhood cancer in the DCOG-LATER cohort: contributions of radiation dose, exposed cranial volume, and age. Neuro Oncol 21 ( ... review of radiation-associated hypothyroidism.[ 20 ] Among seven cohorts (250 patients), the dose associated with a 50% risk (D50) of hypothyroidism ...

... limited but reported similar findings (SOE: low). Two cohort studies found higher doses of long-term opioid therapy associated with increased ... of overdose or overdose mortality (SOE: low). One cohort study found higher dose of opioids associated with increased risk of all- ...

... these interventions. Table 7-D Spinal anesthesia (Different doses): Cohort studies. Mortality (30-day) . One cohort study 82 ( ... 03, 0.51; p = 0.004). Similarly, one cohort study 82 (n = 291) reported a statistically significant difference ... Bradycardia was reported in two RCTs 61 , ...

... both groups and 45–50 in the Stein cohort study. The rFVIIa dose range of 40–200 μg/kg in the ... received just one dose. Patients in the Gelsomino cohort 121 received the lowest doses of rFVIIa in all of the cohort studies, ...

... not reached. RR was similar in the two-dose cohorts, with fewer adverse events at the lower dose, leading to FDA approval of the 200-mg ... infusion administered every 3 weeks) of the trial dose given as 3 mg/kg IV over 30 ... I expansion cohort trial ( NCT02383212 ) that required patients to have at ...